In addition, Maayah et al., have demonstrated that inhibition of AhR/CYP1A1 pathway protects against breast cancer initiation and adduct formation in human epithelial breast MCF10A cells [23]. This evidence concerns the gene CYP1A1 and breast carcinoma.